Revolve Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Buy
7,998
+177
+2% +$38.1K 0.21% 68
2026
Q1
$1.7M Buy
7,821
+267
+4% +$59.2K 0.22% 64
2025
Q4
$1.73M Sell
7,554
-1
-0% -$228 0.2% 65
2025
Q3
$1.75M Buy
7,555
+150
+2% +$30.5K 0.21% 63
2025
Q2
$1.37M Sell
7,405
-143
-2% -$26.6K 0.18% 66
2025
Q1
$1.58M Buy
7,548
+269
+4% +$52.3K 0.23% 61
2024
Q4
$1.29M Buy
7,279
+3,064
+73% +$563K 0.19% 64
2024
Q3
$832K Buy
4,215
+1,081
+34% +$202K 0.13% 84
2024
Q2
$538K Buy
3,134
+51
+2% +$8.45K 0.09% 100
2024
Q1
$561K Buy
3,083
+282
+10% +$48.6K 0.1% 97
2023
Q4
$434K Sell
2,801
-251
-8% -$36.6K 0.08% 101
2023
Q3
$455K Buy
3,052
+254
+9% +$37.3K 0.1% 91
2023
Q2
$377K Sell
2,798
-137
-5% -$20.1K 0.09% 100
2023
Q1
$468K Sell
2,935
-13
-0.4% -$1.99K 0.12% 83
2022
Q4
$476K Buy
2,948
+336
+13% +$51.5K 0.14% 79
2022
Q3
$351K Buy
2,612
+5
+0.2% +$717 0.12% 82
2022
Q2
$399K Buy
2,607
+61
+2% +$9.32K 0.13% 80
2022
Q1
$413K Buy
2,546
+594
+30% +$86.3K 0.12% 84
2021
Q4
$264K Buy
+1,952
New +$231K 0.08% 119

Other funds holding ABBV

Revolve Wealth Partners's ABBV Position: Q2 2026 in Review

Revolve Wealth Partners increased its AbbVie (ABBV) stake by 2.3% in Q2 2026, buying an estimated $38.1K and bringing the position to 7,998 shares worth $2.01M. The position accounts for 0.21% of the portfolio, ranked #68.

Revolve Wealth Partners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Revolve Wealth Partners held 7,998 shares of AbbVie worth $2.01M as of Q2 2026.
  • Revolve Wealth Partners bought 177 AbbVie shares in Q2 2026, an estimated $38.1K.
  • AbbVie made up 0.21% of Revolve Wealth Partners's portfolio in Q2 2026, its #68 holding.
  • Revolve Wealth Partners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Revolve Wealth Partners's 13F filing for Q2 2026, filed 9 Jul 2026.